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Mapping, and ultimately preventing, the dissemination of infectious agents is an
important topic in public health. Newly developed molecular–microbiological methods
have contributed significantly to recent advances in the efficient tracking of the noso-
comial and environmental spread of microbial pathogens. Not only has the application of
novel technologies led to improved understanding of microbial epidemiology, but the
concepts of population structure and dynamics of many of the medically significant
microorganisms have advanced significantly also. Currently, genetic identification of
microbes is also within the reach of clinical microbiology laboratory professionals
including those without specialized technology research interests. This review sum-
marizes the possibilities for high-throughput molecular–microbiological typing in ade-
quately equipped medical microbiology laboratories from both clinical and fundamental
research perspectives. First, the development and application of methods for large-scale
comparative typing of serially isolated microbial strains are discussed. The outcome of
studies employing these methods allows for long-term epidemiologic surveillance of
infectious diseases. Second, recent methods enable an almost nucleotide-by-nucleotide
genetic comparison of smaller numbers of strains, thereby facilitating the identification of
the genetic basis of, for instance, medically relevant microbiological traits. Whereas the
first approach provides insights into the dynamic spread of infectious agents, the second
provides insights into intragenomic dynamics and genetic functionality. The current state
of technology is summarized, and future perspectives are sketched.
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I N T R O D U C T I O N
Analysis of the dynamics of nosocomial infections
caused by pathogenic bacterial species depends
heavily on the accurate identification of these
taxonomic entities, including the adequate defini-
tion of subspecific strains and clones. Whereas a
strain is usually defined as a pure microbiological
culture obtained in the clinical microbiology
laboratory [1], diagnosing a clone requires addi-
tional investigation [2]. Whether clone definition is
pursued in depth or more superficially depends on
the nature of the questions to be answered. If
straightforward local or institutional outbreaks
of infectious diseases need to be delineated, a more
shallow approach usually suffices. Data are gen-
erated at high speed for immediate comparison of
the characteristics of small numbers of strains. No
reference to archival isolates needs to be made;
only superficial measures of similarity or identity
need to be assessed for a pair of incidental bacterial
isolates. When detailed genetic analyses of popu-
lations are to be made, however, various genetic
and phenotypic approaches need to be implement-
ed, and their data combined. Nevertheless, taxon-
omy, evolutionary genetics and straightforward
microbiological epidemiology share the same
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technological approaches, and, in a sense, the
various disciplines center around a small number
of common concepts; currently, nucleic acid poly-
morphism and its reproducible, specific and sen-
sitive detection are at the core of all of these
microbiological sciences [3,4]. The quality of the
microbial type assessment depends on the choice
of technology and the interpretation of the experi-
mental data within a sound theoretical framework
of, for instance, comparative genetics, Linnean-
style taxonomy, or clinically oriented hospital epi-
demiology. The current state of laboratory tech-
nology facilitates two major high-throughput
typing approaches: large numbers of strains can
be compared, their fingerprints cataloged, and
their mode of epidemiologic spread assessed in
minute detail; or limited numbers of strains can be
completely genetically indexed by a variety of
high-technology molecular strategies. This gener-
ates complete inventories of the gene content of
an individual strain, and highlights genetic varia-
tion in its most subtle detail. Both high-throughput
methodologies, although fundamentally different
in experimental outcome, will be discussed
below.
C O N C E P T U A L A N D
T E C H N O L O G I C A L V O C A B U L A R Y
O F H I G H - T H R O U G H P U T T Y P I N G
T E C H N O L O G I E S
Historically, subspecies identification of microbial
pathogens was performed with technologies
aimed at the definition of a certain phenotype only.
Susceptibility to infection by bacteriophages [5] or
the presence of certain sugar or protein moieties at
the cell surface are useful characteristics for mak-
ing this distinction. For a food-borne enteric patho-
gen such as Campylobacter jejuni, for instance, two
very important typing schemes have been fre-
quently used. The serotyping methods that were
independently developed by Penner and Lior have
contributed significantly to the development of
successful surveillance programs for C. jejuni [6].
These methods allowed for the analysis of large
numbers of strains, and, using well standardized
techniques, longitudinal studies, often covering
large geographic areas, have been presented in
the past. Unfortunately, high-throughput applica-
tions of this type of laboratory methodology are
restricted to some of the larger reference labora-
tories. Although effective microbial typing can be
performed, systems such as these clearly lack
flexibility; data generation may take a long time,
which precludes timely reporting of data that
should have an anti-outbreak or anti-epidemic
impact. In addition, the reproducibility of this
class of methods might suffer from phenotype
switching of the bacteria [7]. Consequently, alter-
native methods have been designed which better
accommodate the needs of the microbiological
epidemiologist. Most of these methods are nucleic
acid oriented, but not all of them are suitable for
high-throughput applications. The high-through-
put potential of some of the methods is discussed
below in more detail.
Probing large collections of microbial isolates
for genetic polymorphism by techniques provid-
ing a partial genetic signature provided the frame-
work for classical high-throughput typing. Two
different approaches can be recognized here: com-
parative versus library typing systems, employing
outbreak investigation systems versus surveil-
lance typing systems, respectively [8]. In these
cases, it is the number of microbial isolates studied
that defines ‘high-throughput’, not the amount of
genetic polymorphism identified for just a few
strains. This category of methods revolves around
a large cohort of laboratory techniques. Various
generations of technologies can be distinguished:
plasmid fingerprinting was succeeded by South-
ern blotting procedures, pulsed-field gel electro-
phoresis (PFGE), PCR approaches and, ultimately,
DNA sequencing of limited regions in microbial
genomes (reviews: Goering [9], Jarvis [10] and
Bingen [11]). All of the technologies have their
specific advantages and disadvantages, many of
which have been discussed in detail in the litera-
ture (for critical considerations, see Maslow and
Mulligan [12], Struelens [13], Tenover et al. [14],
Blanc et al. [15], Van Belkum [16], and Vanee-
choutte [17]). For the current review, it suffices
to conclude that typing methods suited to com-
parative typing and library typing are at the dis-
posal of all microbiologists, whether their
diagnostic interests are more clinically or more
fundamentally oriented.
Genomic sequencing of multiple strains of a
single species provides a wealth of data for limited
numbers of isolates [18]. The full extent of the
genetic variation among a few ‘individuals’ can
be completely defined. This type of approach is
essential for defining differences in gene content,
and consequent differences in virulence potential
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or other biological capacities. Besides whole gen-
ome sequencing, methods such as high-through-
put amplification fragment length polymorphism
(AFLP) analysis are good alternatives. By perform-
ing many different selective PCR-based AFLP
reactions using a single DNA template prepara-
tion derived from a single microbial isolate,
approximately 30–40% physical genome coverage
can be achieved [19]. This type of approach facil-
itates the acquisition of novel (gene) probes or
DNA sequences intimately associated with phe-
notypic traits [20–23]. In addition, these approaches
also identifygenetic exchange processeson thebasis
of gene sharing among otherwise unrelated classes
of microbes [24]. The availability of these high-tech-
nology possibilities for microbial typing is as yet
restricted to a small number of academic and com-
mercial institutions only.
In the following major sections, methods suited
to these two categories of high-throughput typing
approaches will be introduced in more detail
and critically evaluated. The various different ap-
plications of the techniques will be surveyed (see
Figure 1 for a schematic summary of the preceding
sections), and possible future avenues will be dis-
cussed.
Figure 1 Flow scheme highlighting the various microbial typing routes currently employed in the molecular–medical
microbiology laboratory. The box on the left summarizes the most modern technological approach for the elucidation of
nosocomial outbreaks of infectious diseases. Comparative typing of limited numbers of strains collected in a narrow time
frame generates genetic signatures, usually visualized as banding pattern-based molecular fingerprints. The box on the
right sketches the investigative route; the application of high-technology genomics and proteomics strategies allows for the
collection of unprecedented volumes of genetic characteristics, usually for a limited number of strains only. The central
route represents high-throughput microbial typing in its classical sense. Large numbers of geographically diverse microbial
isolates are characterized with the help of standardized molecular technology. The major outcomes of these studies
describe clonal complexes of pathogens that share certain genetic characteristics.
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H I G H - T H R O U G H P U T M I C R O B I A L
T Y P I N G F O R E P I D E M I O L O G I C
P U R P O S E S
This section describes the development, validation
and clinical application of methods suitable for
high-throughput application in the field of micro-
bial epidemiology. Examples will be provided that
identify methods specifically suited to the analysis
of certain microbial species. The concepts that are
thus highlighted can be extrapolated for the study
of essentially all other microbial species that are
clinically relevant and isolated in numbers neces-
sitating high-throughput epidemiologic typing.
Development of high-throughput methods for
Staphylococcus aureus
The development of high-throughput methods for
typing bacterial pathogens requires careful assess-
ment of the qualities of candidate systems. There-
fore, it is extremely important not only to compare
methods with each other, but also to define the
robustness or weakness of individual methods.
Typing experiments need to be reproducible,
whereas data interpretation and communication
should be easy and straightforward. For Staphylo-
coccus aureus, for instance, many comparative typ-
ing studies have been performed in order to
identify the optimal typing technology. These
include multicenter evaluations of the efficacy of
some of the techniques. A first exemplary study
was initiated by scientists from the Centers for
Disease Control and Prevention (CDC, Atlanta,
USA), and described the establishment of a well
defined collection of strains which were genetic-
ally typed using a combination of classical and
molecular methods [25]. It appeared that none of
the methods completely failed; as long as the
laboratory expertise was good, methods usually
generated epidemiologically concordant data.
This initial study paved the way for several multi-
center trials employing a standard collection of
strains and focusing on the validation of a single
high-throughput genotyping procedure.
Arbitrary primer PCR [26], repetitive element-
based PCR [27,28] and PFGE [29–31] were evalu-
ated with respect to inter-center reproducibility
and the feasibility of data transfer between centers.
The results suggested that the PFGE procedure
might possibly be developed into a surveillance
typing system, as was recently also confirmed by
multicenter analysis of PFGE performance for typ-
ing of Bordetella pertussis [32]. Detailed protocols
could be turned into an experimental system suit-
ed for the establishment of a network of institu-
tions that focus on epidemiologic typing by PFGE.
Increases in the speed of the PFGE procedure and
ease of interpretation of its experimental output
could still strongly improve its usefulness [33].
Several current efforts, some European Union
(EU) sponsored, are aiming at the fine-mapping
of the international dissemination of major
clones of methicillin-resistant Staphylococcus aureus
(MRSA). It is interesting to note that in the case of
MRSA, the diversity noted in the resistance-encod-
ing genetic element (staphylococcal cassette chro-
mosome mec) is also important in the assessment of
the nature of the epidemiologic behavior [34].
Most of the methods introduced above rely on
the generation of banding pattern-based DNA
fingerprints. These are often difficult to reproduce,
and unbiased interpretation is also difficult to
achieve. For this reason, the development of binary
systems (e.g. those generating simple yes/no
hybridization output) was undertaken for strains
of S. aureus as well. Binary typing of S. aureus relies
on the recognition of bacterial DNA by a set of
probes that either find or do not find a genomic
complement. A system comprising 12 such probes
has been developed, validated and tested in var-
ious clinical studies [35–40]. Recently, this novel
assay has been validated in an international multi-
center study, aimed at assessing its inter-center
reproducibility [41]. This latter study revealed
that, despite the simple layout of the binary typing
protocol, many laboratories had problems in iso-
lating DNA sufficiently pure for high-quality ana-
lyses. However, if DNA preparations were
distributed among the study participants, the bin-
ary genetic codes were correctly assessed in all of
the participating centers. This illustrates that bin-
ary typing may evolve into a useful library typing
system once the DNA isolation protocol is
improved. The study also underscores the fact
that, despite simple and straightforward labora-
tory protocols, tests may present experimental
problems to those researchers and clinicians per-
forming the assays for the first time.
Recently, DNA sequencing of various house-
keeping genes for a variety of S. aureus strains
resulted in the development of a so-called multi-
locus sequence typing (MLST) scheme and data-
base [42]. This methodology has already proved its
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value: major clones, also distinguished with
respect to virulence or other ecological features,
could be adequately recognized [43,44] (see also
below). The MLST data are accessible at a website,
where database interrogation can be performed by
outsiders. Most importantly, the technological
formats of both the binary typing system and
the MLST system have proved their value, and,
because they consist of a simple reversed hybridi-
zation system and direct nucleotide sequencing,
respectively, both concepts can be easily translated
into a format involving DNA microchip technol-
ogy [45,46].
In summary, high-throughput typing methods
have been developed, but most of these still need
to be translated into a format suited to the routine
medical microbiology laboratory. At present, the
PFGE-mediated strategies are the most popular,
and are considered to represent the standard for
many microbial species. However, since PFGE
generates banding patterns, it will be displaced
by the more objective binary approaches.
Although binary typing is currently best suited
for immediate implementation in the routine
laboratory, it is anticipated by most researchers
in the field that sequence-based strategies will
prevail in the end.
Existing high-throughput typing
methodologies
As shown above, epidemiologic typing is an art
rather than an established technology. For many
species, high-throughput typing is as yet an un-
achieved goal, and the appropriate methods are
still limited in number. However, some note-
worthy successes have been reported in the
characterization of certain pathogenic microbial
species. Two examples will be highlighted below.
IS6110 RFLP mapping and spoligotyping
for Mycobacterium tuberculosis
Strain identification of the pulmonary pathogen
Mycobacterium tuberculosis is very important from
the public-health perspective. For this reason,
much attention has been focused on the develop-
ment of versatile library typing systems. The first
broadly accepted high-throughput mycobacterial
typing system was one based on the assessment of
restriction fragment length polymorphism (RFLP)
associated with the various integration sites of the
insertion element IS6110 [47–49]. This ultimately
led to the definition of an experimental consensus
protocol, giving a detailed description of the
IS6110 RFLP technology which should also be
implemented by non-reference centers. Interest-
ingly, the results of the explorations could often
be directly compared to entries in a central finger-
print database [50]. The technology has been
applied in a wide range of clinical–epidemiologic
studies, a review of which is not intended here.
Clearly, the availability of a standardized technol-
ogy has had a major impact on developments in
this field; thousands of strains were analyzed,
giving rise to detailed identification schemes
and resolution of outbreak scenarios. In addition,
various surprisingly important international
clones of M. tuberculosis were identified [51,52].
The example of tuberculosis guided epidemiolo-
gists working on other infectious disease agents.
Although it has been convincingly demon-
strated that the rate of change of the mycobacterial
IS6110 fingerprint is within the theoretical limita-
tions posed by short-term epidemiology [53], mild
criticism has recently been made of IS6110 RFLP
analysis. Strains with limited numbers of IS6110
were discovered [54], and it was suggested that
IS6110-related polymorphism was not random in
M. tuberculosis, thereby possibly biasing epidemio-
logic studies [55]. The latter phenomenon was
suggested because of rather extensive band shar-
ing between otherwise unrelated strains, implying
that non-significant overlap might confuse the
epidemiologic interpretation of the data. This gen-
erated a search for additional typing targets in the
well conserved M. tuberculosis genome [56,57].
Essentially, all of the novel typing targets dis-
covered belong to various classes of repetitive
DNA. DNA repeats have been demonstrated to
be highly variable in various microbial species,
and, in several cases, repeat polymorphism can
be used as a means of genetic characterization [58].
Among the mycobacterial repeats were the Myco-
bacterial Interspersed Repetitive Units (MIRUs)
[59], various Variable Number of Tandem Repeat
(VNTR) loci [60], and additional simple repeats
such as (TTC)n [61]. Most notable was the discov-
ery of a direct repeat locus consisting of a large
number of directly repeated domains alternating
with sequence-variable spacer domains [62]. Since
the spacers are variable in sequence and were
shown to be selectively absent from strain to strain,
cross-spacer PCR allows for the generation of
sequence-variable material that can be directly
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analyzed by reversed hybridization [63,64]. This
led to the development of a second successful
mycobacterial high-throughput library typing sys-
tem, the binary result of which consists of an array
of positive and negative hybridization signals. The
system was called spoligotyping, and preliminary
studies revealed its power in the detection of
epidemiologic clusters [65]. However, in a multi-
center trial, the method still performed less ade-
quately than did IS6110 RFLP analysis [66]. This is
probably because high-stringency hybridization
tests need optimization in each and every labora-
tory where the procedure is applied, or, as the
authors of the multicenter paper state, ‘The repro-
ducibility and discriminatory power of some
methods might increase if the methods are
improved.’ Since spoligotyping relies on PCR, it
can be directly applied to clinical samples, thereby
circumventing the usually lengthy cultivation
step. This is not possible for the IS6110 procedure,
for which micrograms of purified mycobacterial
DNA are required. Furthermore, addition of extra
spacer probes to the arrays will increase the reso-
lution of the system [64]. In short, the epidemio-
logic surveillance of mycobacterial infections is
now facilitated by two well validated systems that
have been described in recent literature. These
represent the first examples of the clinical value
that such library typing systems can have.
In conclusion, M. tuberculosis provides an exam-
ple of a bacterial species for which several well
standardized, powerful methods of epidemiologic
characterization have been developed. RFLP-
based fingerprints can be matched between labora-
tories, and large databases can be exchanged. In
addition, a binary system is available, and
although it does not yet have the resolving power
of RFLP mapping, the method holds promise for
the future. This is underscored by the fact that
DNA chip technology has already been success-
fully implemented for diagnosing species as well
as rifampicin resistance gene mutations for Myco-
bacterium spp. [67]. This provides another techno-
logical platform to which the spoligotyping system
can be easily added. This will further widen the
array of technologies suitable for epidemiologic
tracking of M. tuberculosis.
Multilocus sequence typing for Neisseria
meningitidis
The meningococcus Neisseria meningitidis is a pri-
mary cause of sometimes epidemic meningitis,
most frequently in young children [68]. The public
anxiety caused by this pathogen in itself is a
sufficient reason for trying to keep track of the
(worldwide) dissemination of the pathogen
through human populations. This requires intri-
cate genetic typing strategies, for which many
different procedures have been described over
the past decade. The methodology has ranged
from simple PCR approaches [69], to sequencing
of surface-associated protein genes [70], to whole
genome sequencing, which has helped to catalog
the broad array of chromosomal loci that can be
used for the genetic identification of strains [71].
However, the most powerful and simultaneously
portable approach to meningococcal isolate char-
acterization turned out to be MLST, which essen-
tially summarizes the nature of the mutations
detected in several neisserial housekeeping genes
[72,73]. Gene alleles are given numbers, and the set
of numbers defines the sequence type or allelic
profile. Major clones are exclusively identified on
the basis of this number. For meningococci, the
first MLST study employed sequences of six such
genes [74]; the current scheme harbors seven target
genes (abcZ, adk, aroE, fumC, gdh, pdhC, and pgm)
[75,76]. The data thus obtained were congruent with
data gathered previously with the help of ‘classical’
genetic typing. MLST, in principle, generates simple
four-letter codes identifying various mutant alleles.
This provides a binary system, the data of which are
easy to interpret and can be conveniently cataloged
and matched, and which is also very well suited to
high-throughput applications.
MLST correctly identified major meningococcal
clones already identified by prior comparative
analyses. The fact that MLST specifically segre-
gates the important clones in N. meningitidis sug-
gests that most other bacterial species will also be
amenable to the MLST approach, since the menin-
gococcus is an example of a bacterial species in
which gene exchange occurs randomly and at high
frequency [77,78]. Recently, the MLST procedure
also proved its value for short-term outbreak man-
agement. The MLST approach correctly identified
the chain of transmission in an outbreak of infec-
tions involving various types of meningococci [75].
It was demonstrated that MLST was easier to
interpret than PFGE and, even more importantly,
the MLST data allowed for the assessment of
precise genetic relatedness among the strains cap-
tured during the outbreak of infections. It was
shown that the MLST procedure in itself can also
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be applied directly, without an intermediate culti-
vation step, to infected cerebrospinal fluid samples
[79]. Finally, the MLST data are freely accessible at
the Oxford MLST website, so that everyone can
compare their personal data with a worldwide
collection of N. meningitidis strains (http://
mLst.zoo.ox.ac.uk).
In summary, M. tuberculosis and N. meningitidis
are important and globally occurring microbial
pathogens, the invasiveness and antimicrobial
resistance of which are important denominators
of clinical relevance. It is absolutely essential to
keep track of the more virulent or more resistant
clones of these bacterial species. Consequently,
library typing systems have been developed,
and the use of these important high-throughput
techniques is currently spreading.
Computerized data assessment and
communication through networking
Efficient interpretation of experimental data and
timely dissemination of these results are essential
requirements for the success of a high-throughput
surveillance typing system. Therefore, several
guidelines have been produced for most of the
typing systems available to date. The mathemati-
cal foundations for determination of typability,
reproducibility and discriminatory power were
proposed in the late 1980s [80–82], and several
commercially available computer programs dedi-
cated to the calculation of fingerprinting pattern
relatedness are now available (e.g. BioImage or
Molecular Analyst Fingerprinting Plus System)
[83]. However, these programs generally require
visually guided pattern normalization, and as such
are not independent of personal opinion. It is also
vital to include size-standard molecular samples
in every electrophoresis run. An additional dis-
advantage of the banding pattern-based systems is
the fact that gel-to-gel variability is generally large.
Improvements in the quality of the interpretative
software are still necessary [84]. The recently pro-
duced program BioNumerics (Applied Maths,
Kortrijk, Belgium), which allows combined anal-
yses of multiple independent data sets in a simul-
taneous fashion, might be an important first step in
the right direction (see Gillman et al. [85] for an
example).
In order to generate functional networks for the
efficient exchange of large volumes of microbial
typing data, genotyping technology needs to be
highly standardized. As an example of a fully
automated, standardized system, one could men-
tion the Riboprinter apparatus, a machine that
enables detailed assessment of ribosomal restric-
tion fragment length patterns (Qualicon, Wilming-
ton, DE, USA). This technology, which was
manually explored by Brosch et al. [86], can be
used for various specific forms of microbiological
diagnostics. First, accurate species identification
can be achieved, as was demonstrated, for
instance, for all of the Burkholderia spp. and Sal-
monella enteritidis versus Salmonella typhimurium
[87,88]. Second, certain biotypes or other specific
phylogenetic groups within species boundaries
can be discriminated. Complement-resistant
strains of Moraxella catarrhalis can be distinguished
reliably from their complement-susceptible coun-
terparts [89], and within the species Escherichia coli,
phylogenetic grouping as defined by other tech-
nologies can be efficiently corroborated [90]. It
must be emphasized, however, that this approach
is not successful for resolving every problem; a
certain degree of clonality among the microbial
isolates is mandatory [91,92]. Third, and most
importantly from the perspective of microbiologi-
cal surveillance, the Riboprinter enables longitu-
dinal studies on the historical and present
geographic spread of certain bacterial ribotypes,
and as such paves the way for the establishment of
high-throughput bacterial library typing net-
works. As initial examples of the putative success
of such approaches, the massive spread of an
invasive strain of Haemophilus influenzae type b
was documented to have occurred between 1994
and 1998 in Taiwan [93]. In addition, riboprinting
staphylococci isolated from skin and soft tissue
infections showed that a major clone of a multi-
resistant MRSA strain circulates in Latin America
[94]. The methodology also allows for tracking of
microbes outside of the immediate medical setting.
It was demonstrated that certain strains of Listeria
monocytogenes could be retrieved from food pro-
cessed in the same production plants over many
consecutive years [95]. The latter examples under-
score the fact that, once a technology is well stan-
dardized, it can be applied for the epidemiologic
characterization of microbial isolates that have been
isolated from diverse sources at various times.
Another example of a successful multicenter
typing approach is provided by PulseNet, a
national US effort initially started to survey clus-
ters of infections related to the consumption of
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contaminated food, as for instance those caused by
E. coli O157:H7 [96,97]. Applying a 1-day PFGE
protocol employing standard laboratory equip-
ment and reagents (Bio-Rad), at present labora-
tories in 46 US states are involved in the
epidemiologic tracking of pathogens as diverse
as L. monocytogenes [98] and C. jejuni [99]. Among
the participating institutions are laboratories from
the Food and Drug Administration and from the
Department of Agriculture [100], and the future of
the system is bright; PulseNet has already proved
its ability to delineate major outbreaks of appar-
ently unrelated infections several times [101–103].
The fact that the PFGE fingerprints can be
exchanged and interrogated through the Internet
strengthens the applicability of the methodology
[99]. Also, in Europe, various multicenter efforts
aimed at the generation of ‘PulseNet homologs’
are ongoing. Examples are provided by various
studies sponsored by the EU and which have
become known primarily by their acronyms:
among others, these are HARMONY (Harmoniza-
tion of Antibiotic Resistance measurement, Meth-
ods of typing Organisms, and ways of using these
and other tools, to increase the effectiveness of
Nosocomial Infection control, coordinated by Dr
Barry Cookson, Public Health Laboratory Service
PHLS, Laboratory for Hospital Infection LHI,
London, UK), ENARE (European Network on
Antimicrobial Resistance Epidemiology, coordi-
nated by the University Medical Center Utrecht,
The Netherlands), GENE (Network for Automated
Bacterial Strain Fingerprinting in Europe, coordi-
nated by Dr Sylvain Brisse, University Medical
Center Utrecht, Utrecht, The Netherlands), and
ENEMTI (European Science Foundation Network
for Exchange of Microbial Typing Information,
coordinated by Dr Kevin Towner, PHLS, Notting-
ham, UK). Essentially, all of these studies are
aimed at the development or refinement of
DNA fingerprinting systems for microbes that
generate inter-center, reproducible data that are,
most importantly, easily communicable.
In short, recent improvements in the availability
of dedicated software, automated typing options
and access to the Internet have facilitated the
establishment of multicenter library typing net-
works. These have already shown their impor-
tance in preventing or stopping outbreaks of
infections. The availability of genomics and
high-throughput sequencing technologies will
lead to novel stimuli in the near future.
H I G H - T H R O U G H P U T T Y P I N G
T H R O U G H C O M P A R A T I V E
G E N O M E S C A N N I N G
Typing is primarily used for comparing large
volumes of different microbial strains. Detailed
comparisons of small numbers of strains are
important as well, and can be considered to con-
stitute high-throughput typing when the amount
of detail that is produced is extremely large, as is
the case with genome sequencing. High-through-
put typing efforts are strongly affected or even
promoted by the current availability of whole
genome sequences and the possibilities of per-
forming comparative genomics aided by these
full-chromosome sequences [104]. The first exam-
ples of whole genome sequences relating to micro-
biology were those determined for various
bacteriophages [105]. These relatively short gen-
ome sequences provided a wealth of information
on gene function, and, obviously, similar expecta-
tions attended the publication of the full sequence
of the first bacterial genomes.
The number of full sequences in the public
domain has expanded rapidly over the past few
years. The availability of this multitude of com-
plete genome sequences for clinically relevant
microorganisms will generate a complete survey
of all the intrinsically variable genomic regions
that may in the end prove to be excellent typing
targets [106]. Comparative genomics has been
instrumental in cataloging genome-wide poly-
morphism, and it has contributed greatly to the
optimization of nucleic acid typing methods. For
some bacterial species, for instance, multiple gen-
ome sequences have been published, facilitating
their side-by-side comparison, and thereby allow-
ing the identification of large numbers of variable-
sequence domains which can be translated into
typing target sequence motifs [107–109]. This type
of approach will eventually generate novel assays
that can be implemented in the day-to-day activ-
ities of the diagnostic medical microbiology
laboratory. Comparative genomics will facilitate
the identification of those targets shared by many
microbes, enabling the design of molecular tests
that can be uniformly applied to a variety of
microbial species.
From the technical perspective, whole genome
sequencing in itself has led to tremendous advanc-
es in high-speed nucleic acid sequencing automa-
tion. The novel technical ‘tricks’ will ultimately
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also improve the typing procedures themselves.
Already, computerized analysis of genetic data
has vastly improved within only a few years and,
in the meantime, bio-informatics has become ser-
ious science [110]. Managing large data deposi-
tories, calculating whole genome homologies [111]
and performing comparative or phylogenetic com-
putation will expand the possibilities for adequate
data interpretation and exchange [112]. Finally,
when full gene complements are known for a
microbial species, genomic typing based on the
selective presence of certain groups of genes can in
principle be linked to biological characteristics
[113,114]. For instance, the assessment of the dif-
ferential presence of virulence determinants or
antimicrobial resistance genes can provide geno-
mic typing data that can predict a certain pheno-
type. The evolutionary dynamics of gene content
may, eventually, be helpful also in formulating a
theoretical description of the nature of the earliest
eukaryotic cells on earth [115,116].
Below, two examples of pathogens for which
whole genome sequences are available will be
discussed in more detail. For both Helicobacter
pylori and C. jejuni, the impact of genomics on
our understanding of bacterial epidemiology
and pathogenicity will be summarized.
Helicobacter pylori comparative genomics
In January 1999, the full genome sequences of two
isolates of the gastric pathogen Helicobacter pylori
were published [108]. Interestingly, it became
immediately clear that there were differences
between the two genomes. One of the strains
harbored a genome that was 24 036 nucleotides
shorter than that of the other. The smaller genome
contained 95 predicted open reading frames less,
and, irrespective of the size differences, between
6% and 7% of all genes appeared to be specific to
each strain. In addition, different numbers of the
insertion elements IS605 and IS606 were noted.
This degree of diversity was in agreement with
earlier findings [117], and illustrated that isolate-
specific sequence motifs, suited for epidemiologic
tracking, for instance, were frequent. Furthermore,
within certain genes, clear variability was
observed. For example, many genes contain
repeated nucleotides or nucleotide motifs [118].
This size variation between the two genome
sequences had already been documented [119],
indicating that these regions could be used for
monitoring genetic variation or differences in gene
expression among strains of H. pylori [120]. Com-
parative and functional genomics approaches, all
of which were firmly based on the available gen-
ome sequences, led to the identification of a novel
sugar transferase gene [121] and the putative hor-
izontal transfer of genes encoding restriction mod-
ification systems [122], as well as the detection of
several paralogous gene families (genes that are at
different chromosomal locations but share struc-
tural features suggesting that they are derived
from a common ancestor) of outer-membrane pro-
teins [123]. Finally, the genetic diversity estab-
lished for H. pylori as a highly specialized,
human-adapted microbial species has been con-
firmed by protein analyses, which may eventually
shed some light on the mechanisms of coevolution
between host and pathogen [124].
Campylobacter jejuni comparative genomics
Campylobacter jejuni is an important food-borne
pathogenic bacterial species. Besides the direct
effects of the infection, chronic sequelae, such as
the paralytic Guillain–Barre syndrome (GBS), con-
tribute to the overall morbidity caused by C. jejuni
[125]. Of course, many typing techniques were
developed for this species, including MLST ap-
proaches [126] and genome sequence-based fluor-
escent AFLP analysis [127]. In February 2000, the
genome sequence was presented [128]. The prime
initial finding was that, as with the H. pylori gen-
ome, many simple sequence repeats were identi-
fied, most of which were demonstrated to be
variable in length. Interestingly, some of these
phase-variable genes are involved in the biosynthe-
sis of lipooligosaccharide (LOS) moieties, which
affects the structure of the immunologically
exposed bacterial surface [129]. These structures
are also involved in the immunologic response
giving rise to GBS. The detrimental effects are
due to molecular mimicry between the bacterial
LOS and the gangliosides present on human per-
ipheral nerve tissue [130]. It has been demon-
strated before that strains giving rise to GBS
are genetically heterogeneous [131–133]. This sug-
gests that, if bacterial factors are involved in the
development of GBS, comparative genomics
approaches should be employed in searching for
them. The LOS gene cluster as identified by whole
genome sequencing is an excellent candidate locus
in this respect, and the first searches for GBS
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 9, 86–100
94 Clinical Microbiology and Infection, Volume 9 Number 2, February 2003
determinant genes in the LOS region have been
quite successful (P. Godschalk, unpublished
observations) [134]. This again emphasizes that
high-throughput screening of sets of genes identi-
fied by genomic sequencing can give clues about
microbial pathogenicity, enabling adequate mar-
kers to be translated into diagnostic tests. In addi-
tion, the genome sequence has been exploited for
the identification of cell surface determinants [135]
and chemotactic behavior [136]. Last, but not least,
the C. jejuni open reading frames detected by whole
genome sequencing can all be immobilized physi-
cally and separately on DNA chips. This enables
whole genome comparisons to be performed in an
extremely high-density fashion for multiple strains.
The first experiments have already demonstrated
‘extensive genetic diversity’ [137].
In conclusion, for both H. pylori and C. jejuni, the
availability of the genome sequence has made
possible a new type of biological exploration:
whole genome gene sets (or partial gene sets)
can now be compared in exquisite detail between
strains of a species, and also between strains
belonging to different species [138]. The link
between such studies and certain pathogenic types
will lead to the identification of the microbial
genes involved in certain types of (chronic) infec-
tions or postinfectious sequelae. Ultimately, this
will provide the medical microbiologist with novel
typing tools that will not only assist in the identi-
fication of universally spreading pathogens, but
will also unveil the possible pathogenicity of cer-
tain microbial strains. In this way, high-through-
put genetic comparison of just a few clinical
isolates paves the way for high-throughput typing
of large numbers of strains.
F U T U R E P E R S P E C T I V E S
Despite their immense popularity in both clinical
and fundamental infectious disease research,
nucleic acid-based tests move slowly into every-
day clinical practice [139,140]. This is particularly
true for epidemiologic test systems. At present, the
number of commercially available assays is lim-
ited, and they are rather expensive; consequently,
the possibility of concerted typing actions depends
strongly on external financial support. In contrast,
distinct possibilities for high-throughput genotyp-
ing are large in number. This indicates that
methods now suited for fundamental research
application need to be transformed into methods
that are easily applicable and generally available.
As has already been demonstrated for various
microbial pathogens, microbiological typing is
important not only for tracking and blocking noso-
comial outbreaks of infections, but also for the
identification of clones that are extremely impor-
tant in human disease. In the very near future,
vigorous efforts should be made to supply the
medical world with additional high-throughput
technologies for the monitoring of the wide array
of emerging infectious agents that is currently
threatening universal health systems.
The recent explosion of microbial genomics
initiatives provides ample opportunities for the
development of novel approaches. Besides the
technical possibilities for deducing complete
inventories of microbial genome polymorphism
and translating those into innovative typing pro-
cedures, selective gene presence can generate typ-
ing data that can be directly linked to phenotypic
characteristics such as virulence and antimicrobial
resistance. In addition, it is now time to start
analyzing genome–genome interactions using
the same methodology that has been so successful
for the characterization of individual genome
molecules [141,142]. Elucidation of the genetic
basis of host–pathogen interplay, functional diver-
sity, genome plasticity and lateral gene transfer
will enhance our insights into genetic diversity
and will ultimately lead to a complete inventory
of those genetic elements important in individual
human susceptibility to infectious diseases.
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